Search
Fenaperone
go.drugbank.com/drugs/DB21281ExperimentalFenaperone has a monoisotopic molecular weight of 376.22 Da. … Fenaperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Fenaperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Metrenperone
go.drugbank.com/drugs/DB21312ExperimentalMetrenperone has a monoisotopic molecular weight of 407.2 Da. … Metrenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Metrenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Acefylline clofibrol
go.drugbank.com/drugs/DB21353ExperimentalAcefylline clofibrol has a monoisotopic molecular weight of 420.12 Da. … Acefylline clofibrol is a small molecule drug. The usage of the INN stem '-fylline' in the name indicates that Acefylline clofibrol is a N-methylated xanthine derivative.
Nelutroctiv
go.drugbank.com/drugs/DB21554InvestigationalNelutroctiv has a monoisotopic molecular weight of 543.13 Da. … Nelutroctiv is a small molecule drug. Nelutroctiv is under investigation in clinical trial NCT05662215 (A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants).
Sofnobrutinib
go.drugbank.com/drugs/DB21626ExperimentalSofnobrutinib has a monoisotopic molecular weight of 498.19 Da. … Sofnobrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Lacutoclax
go.drugbank.com/drugs/DB21657InvestigationalLacutoclax has a monoisotopic molecular weight of 922.36 Da. … Lacutoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.
Vilzemetkib
go.drugbank.com/drugs/DB21704ExperimentalVilzemetkib has a monoisotopic molecular weight of 642.27 Da. … Vilzemetkib is a small molecule drug. The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.
R906289
go.drugbank.com/drugs/DB19126InvestigationalR906289 is under investigation in clinical trial NCT05308264 (Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)).
Velufenacin
go.drugbank.com/drugs/DB21473InvestigationalVelufenacin has a monoisotopic molecular weight of 362.12 Da. … Velufenacin is a small molecule drug. The usage of the INN stem '-fenacin' in the name indicates that Velufenacin is a muscarinic receptor antagonist.
Copper oxodotreotide Cu-64
go.drugbank.com/drugs/DB15873Approved[A220348] Copper Cu 64 dotatate has a longer half-life and can be produced once a day as opposed to several times a day, and lower positron energy lending to improved spatial resolution. … Copper Cu 64 dotatate is a newly approved Cu labeled somatostatin analog and has several advantages over <sup>68</sup>Ga-labeled somatostatin analogs for positron emission tomography (PET).